Cryptococcal Meningitis in AIDS Patients A Pilot Study of Fluconazole Therapy in 52 Patients View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1990

AUTHORS

B. Dupont , I. Hilmarsdottir , A. Datry , M. Gentilini , P. Dellamonica , E. Bernard , S. Lefort , J. Frottier , P. Choutet , J. L. Vilde , The French study group on fluconazole in cryptococcal meningitis in AIDS patients

ABSTRACT

Cryptococcal meningitis in AIDS patients is liable to relapse and carries a high mortality rate. Standard treatment with amphotericin B and 5-fluorocytosine is limited by toxic effects. In the present study 64 AIDS patients with cryptococcal meningitis were admitted to a multicentre trial of fluconazole given either orally or intravenously. After a loading dose of 400 mg, two dosage regimens were adopted: 150–200 mg, or 400 mg daily for at least 45–60 days; subsequent maintenance therapy was 100 or 200 mg daily for both groups. Forty seven of the 52 evaluable patients were alive and improved or asymptomatic at day 60 and respectively 7 of 14 and 27 of 31 of those on 200 mg or 400 mg per day had negative cultures of the cerebrospinal fluid. Relapse rate under maintenance therapy was 23%. Fluconazole was well tolerated and free from severe side effects. These results merit further study of fluconazole, either alone or in combination. More... »

PAGES

287-303

Book

TITLE

Mycoses in AIDS Patients

ISBN

978-1-4612-7912-9
978-1-4613-0655-9

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4613-0655-9_27

DOI

http://dx.doi.org/10.1007/978-1-4613-0655-9_27

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1031648954


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Pasteur Institute, Hospital and Mycology Unit, 25 rue du Dr. Roux, F 75015, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.428999.7", 
          "name": [
            "Pasteur Institute, Hospital and Mycology Unit, 25 rue du Dr. Roux, F 75015, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dupont", 
        "givenName": "B.", 
        "id": "sg:person.016336531432.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016336531432.87"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Hilmarsdottir", 
        "givenName": "I.", 
        "id": "sg:person.01254727676.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254727676.51"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Datry", 
        "givenName": "A.", 
        "id": "sg:person.0642200611.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642200611.40"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Gentilini", 
        "givenName": "M.", 
        "id": "sg:person.01245715373.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245715373.57"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Dellamonica", 
        "givenName": "P.", 
        "id": "sg:person.0657606671.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657606671.61"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Bernard", 
        "givenName": "E.", 
        "id": "sg:person.01123321174.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123321174.53"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Lefort", 
        "givenName": "S.", 
        "type": "Person"
      }, 
      {
        "familyName": "Frottier", 
        "givenName": "J.", 
        "id": "sg:person.051570254.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.051570254.80"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Choutet", 
        "givenName": "P.", 
        "id": "sg:person.062125544.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.062125544.55"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Vilde", 
        "givenName": "J. L.", 
        "id": "sg:person.01341242120.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01341242120.65"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "The French study group on fluconazole in cryptococcal meningitis in AIDS patients", 
        "type": "Person"
      }
    ], 
    "datePublished": "1990", 
    "datePublishedReg": "1990-01-01", 
    "description": "Cryptococcal meningitis in AIDS patients is liable to relapse and carries a high mortality rate. Standard treatment with amphotericin B and 5-fluorocytosine is limited by toxic effects. In the present study 64 AIDS patients with cryptococcal meningitis were admitted to a multicentre trial of fluconazole given either orally or intravenously. After a loading dose of 400 mg, two dosage regimens were adopted: 150\u2013200 mg, or 400 mg daily for at least 45\u201360 days; subsequent maintenance therapy was 100 or 200 mg daily for both groups. Forty seven of the 52 evaluable patients were alive and improved or asymptomatic at day 60 and respectively 7 of 14 and 27 of 31 of those on 200 mg or 400 mg per day had negative cultures of the cerebrospinal fluid. Relapse rate under maintenance therapy was 23%. Fluconazole was well tolerated and free from severe side effects. These results merit further study of fluconazole, either alone or in combination.", 
    "editor": [
      {
        "familyName": "Bossche", 
        "givenName": "Hugo Vanden", 
        "type": "Person"
      }, 
      {
        "familyName": "Mackenzie", 
        "givenName": "Donald W. R.", 
        "type": "Person"
      }, 
      {
        "familyName": "Cauwenbergh", 
        "givenName": "Geert", 
        "type": "Person"
      }, 
      {
        "familyName": "Van Cutsem", 
        "givenName": "Jan", 
        "type": "Person"
      }, 
      {
        "familyName": "Drouhet", 
        "givenName": "Edouard", 
        "type": "Person"
      }, 
      {
        "familyName": "Dupont", 
        "givenName": "Bertrand", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4613-0655-9_27", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4612-7912-9", 
        "978-1-4613-0655-9"
      ], 
      "name": "Mycoses in AIDS Patients", 
      "type": "Book"
    }, 
    "keywords": [
      "cryptococcal meningitis", 
      "maintenance therapy", 
      "AIDS patients", 
      "subsequent maintenance therapy", 
      "severe side effects", 
      "high mortality rate", 
      "evaluable patients", 
      "fluconazole therapy", 
      "multicentre trial", 
      "loading dose", 
      "relapse rate", 
      "standard treatment", 
      "dosage regimens", 
      "negative cultures", 
      "cerebrospinal fluid", 
      "side effects", 
      "mortality rate", 
      "patients", 
      "amphotericin B", 
      "meningitis", 
      "day 60", 
      "pilot study", 
      "therapy", 
      "fluconazole", 
      "Further studies", 
      "toxic effects", 
      "days", 
      "regimens", 
      "AIDS", 
      "dose", 
      "trials", 
      "daily", 
      "treatment", 
      "study", 
      "rate", 
      "effect", 
      "group", 
      "fluid", 
      "culture", 
      "combination", 
      "results"
    ], 
    "name": "Cryptococcal Meningitis in AIDS Patients A Pilot Study of Fluconazole Therapy in 52 Patients", 
    "pagination": "287-303", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1031648954"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4613-0655-9_27"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4613-0655-9_27", 
      "https://app.dimensions.ai/details/publication/pub.1031648954"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-05-20T07:43", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/chapter/chapter_217.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-4613-0655-9_27"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4613-0655-9_27'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4613-0655-9_27'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4613-0655-9_27'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4613-0655-9_27'


 

This table displays all metadata directly associated to this object as RDF triples.

183 TRIPLES      23 PREDICATES      67 URIs      60 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4613-0655-9_27 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author Nc700a6bbe12f40ad832f93ed02a25aee
4 schema:datePublished 1990
5 schema:datePublishedReg 1990-01-01
6 schema:description Cryptococcal meningitis in AIDS patients is liable to relapse and carries a high mortality rate. Standard treatment with amphotericin B and 5-fluorocytosine is limited by toxic effects. In the present study 64 AIDS patients with cryptococcal meningitis were admitted to a multicentre trial of fluconazole given either orally or intravenously. After a loading dose of 400 mg, two dosage regimens were adopted: 150–200 mg, or 400 mg daily for at least 45–60 days; subsequent maintenance therapy was 100 or 200 mg daily for both groups. Forty seven of the 52 evaluable patients were alive and improved or asymptomatic at day 60 and respectively 7 of 14 and 27 of 31 of those on 200 mg or 400 mg per day had negative cultures of the cerebrospinal fluid. Relapse rate under maintenance therapy was 23%. Fluconazole was well tolerated and free from severe side effects. These results merit further study of fluconazole, either alone or in combination.
7 schema:editor N446927f830a24ef3a4c5ef5bfb49fe5a
8 schema:genre chapter
9 schema:inLanguage en
10 schema:isAccessibleForFree false
11 schema:isPartOf Nbfa7dd4f51a34599bb4eacf72efa4109
12 schema:keywords AIDS
13 AIDS patients
14 Further studies
15 amphotericin B
16 cerebrospinal fluid
17 combination
18 cryptococcal meningitis
19 culture
20 daily
21 day 60
22 days
23 dosage regimens
24 dose
25 effect
26 evaluable patients
27 fluconazole
28 fluconazole therapy
29 fluid
30 group
31 high mortality rate
32 loading dose
33 maintenance therapy
34 meningitis
35 mortality rate
36 multicentre trial
37 negative cultures
38 patients
39 pilot study
40 rate
41 regimens
42 relapse rate
43 results
44 severe side effects
45 side effects
46 standard treatment
47 study
48 subsequent maintenance therapy
49 therapy
50 toxic effects
51 treatment
52 trials
53 schema:name Cryptococcal Meningitis in AIDS Patients A Pilot Study of Fluconazole Therapy in 52 Patients
54 schema:pagination 287-303
55 schema:productId N77e6e3624a99479ba9a4c1e38559cc21
56 Nc35687b2b26b4712a64e5cd87af611ec
57 schema:publisher N4ab774cb1d4f40619b69f937690f923d
58 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031648954
59 https://doi.org/10.1007/978-1-4613-0655-9_27
60 schema:sdDatePublished 2022-05-20T07:43
61 schema:sdLicense https://scigraph.springernature.com/explorer/license/
62 schema:sdPublisher N5f8eb01670ee4eb7a1db51b02d9f051c
63 schema:url https://doi.org/10.1007/978-1-4613-0655-9_27
64 sgo:license sg:explorer/license/
65 sgo:sdDataset chapters
66 rdf:type schema:Chapter
67 N00d5ac0292d647778606abe1d59fb7a5 rdf:first sg:person.062125544.55
68 rdf:rest N786ba776485a4d6e99a1e5a49a305c5c
69 N1c3ba6b76e8c4a71b3fb8e47d7c42107 rdf:first sg:person.01123321174.53
70 rdf:rest N337a1d8442e84e79888e85458d57c4aa
71 N32a52f6e2c1a4ed58c2221c54222ea70 schema:familyName Cauwenbergh
72 schema:givenName Geert
73 rdf:type schema:Person
74 N337a1d8442e84e79888e85458d57c4aa rdf:first Ne81685426f1547eab9ef420f895ffa18
75 rdf:rest Nbd97881f407a43e6bc260056b6b25566
76 N432acead7b7642c4bc68fb82f5f69651 rdf:first Nef1a86e397604e359951aec644b5335e
77 rdf:rest rdf:nil
78 N446927f830a24ef3a4c5ef5bfb49fe5a rdf:first Nbeca377329ff4fa2976c5692d687868a
79 rdf:rest Ndaf8945d9a844cf2b95fff2f1c34e029
80 N4ab774cb1d4f40619b69f937690f923d schema:name Springer Nature
81 rdf:type schema:Organisation
82 N5f8eb01670ee4eb7a1db51b02d9f051c schema:name Springer Nature - SN SciGraph project
83 rdf:type schema:Organization
84 N70952476f3b24364b3379a856059da85 rdf:first sg:person.0642200611.40
85 rdf:rest Nc1aa515c1f23497594563c5702d94dc2
86 N77e6e3624a99479ba9a4c1e38559cc21 schema:name doi
87 schema:value 10.1007/978-1-4613-0655-9_27
88 rdf:type schema:PropertyValue
89 N786ba776485a4d6e99a1e5a49a305c5c rdf:first sg:person.01341242120.65
90 rdf:rest N432acead7b7642c4bc68fb82f5f69651
91 N8404935e08bb4be5afadb691544f087b schema:familyName Van Cutsem
92 schema:givenName Jan
93 rdf:type schema:Person
94 N90112560bbb14d62bf40ba4a292484d6 rdf:first N9321482aaa9a48e991bbe1c07133a0e5
95 rdf:rest N9fc3ae253d9b49dc8a0d5909a428c513
96 N9321482aaa9a48e991bbe1c07133a0e5 schema:familyName Drouhet
97 schema:givenName Edouard
98 rdf:type schema:Person
99 N93590fb21c744e3ebe1bc1148753ad08 rdf:first sg:person.0657606671.61
100 rdf:rest N1c3ba6b76e8c4a71b3fb8e47d7c42107
101 N9fc3ae253d9b49dc8a0d5909a428c513 rdf:first Nd1e8896b13dd49a6a602540a9fcf611f
102 rdf:rest rdf:nil
103 Nad289e6158b94c3cb4bf7347a5689e1e rdf:first N32a52f6e2c1a4ed58c2221c54222ea70
104 rdf:rest Ne167cfa487c845109b35f7e4cd14d071
105 Naf6f0fb515b24f1db63fb2c147e08356 rdf:first sg:person.01254727676.51
106 rdf:rest N70952476f3b24364b3379a856059da85
107 Nbd97881f407a43e6bc260056b6b25566 rdf:first sg:person.051570254.80
108 rdf:rest N00d5ac0292d647778606abe1d59fb7a5
109 Nbeca377329ff4fa2976c5692d687868a schema:familyName Bossche
110 schema:givenName Hugo Vanden
111 rdf:type schema:Person
112 Nbfa7dd4f51a34599bb4eacf72efa4109 schema:isbn 978-1-4612-7912-9
113 978-1-4613-0655-9
114 schema:name Mycoses in AIDS Patients
115 rdf:type schema:Book
116 Nc1aa515c1f23497594563c5702d94dc2 rdf:first sg:person.01245715373.57
117 rdf:rest N93590fb21c744e3ebe1bc1148753ad08
118 Nc35687b2b26b4712a64e5cd87af611ec schema:name dimensions_id
119 schema:value pub.1031648954
120 rdf:type schema:PropertyValue
121 Nc700a6bbe12f40ad832f93ed02a25aee rdf:first sg:person.016336531432.87
122 rdf:rest Naf6f0fb515b24f1db63fb2c147e08356
123 Nd1e8896b13dd49a6a602540a9fcf611f schema:familyName Dupont
124 schema:givenName Bertrand
125 rdf:type schema:Person
126 Nd45718aadc914170aca03525da6c4f50 schema:familyName Mackenzie
127 schema:givenName Donald W. R.
128 rdf:type schema:Person
129 Ndaf8945d9a844cf2b95fff2f1c34e029 rdf:first Nd45718aadc914170aca03525da6c4f50
130 rdf:rest Nad289e6158b94c3cb4bf7347a5689e1e
131 Ne167cfa487c845109b35f7e4cd14d071 rdf:first N8404935e08bb4be5afadb691544f087b
132 rdf:rest N90112560bbb14d62bf40ba4a292484d6
133 Ne81685426f1547eab9ef420f895ffa18 schema:familyName Lefort
134 schema:givenName S.
135 rdf:type schema:Person
136 Nef1a86e397604e359951aec644b5335e schema:familyName The French study group on fluconazole in cryptococcal meningitis in AIDS patients
137 rdf:type schema:Person
138 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
139 schema:name Medical and Health Sciences
140 rdf:type schema:DefinedTerm
141 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
142 schema:name Clinical Sciences
143 rdf:type schema:DefinedTerm
144 sg:person.01123321174.53 schema:familyName Bernard
145 schema:givenName E.
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123321174.53
147 rdf:type schema:Person
148 sg:person.01245715373.57 schema:familyName Gentilini
149 schema:givenName M.
150 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245715373.57
151 rdf:type schema:Person
152 sg:person.01254727676.51 schema:familyName Hilmarsdottir
153 schema:givenName I.
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254727676.51
155 rdf:type schema:Person
156 sg:person.01341242120.65 schema:familyName Vilde
157 schema:givenName J. L.
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01341242120.65
159 rdf:type schema:Person
160 sg:person.016336531432.87 schema:affiliation grid-institutes:grid.428999.7
161 schema:familyName Dupont
162 schema:givenName B.
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016336531432.87
164 rdf:type schema:Person
165 sg:person.051570254.80 schema:familyName Frottier
166 schema:givenName J.
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.051570254.80
168 rdf:type schema:Person
169 sg:person.062125544.55 schema:familyName Choutet
170 schema:givenName P.
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.062125544.55
172 rdf:type schema:Person
173 sg:person.0642200611.40 schema:familyName Datry
174 schema:givenName A.
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642200611.40
176 rdf:type schema:Person
177 sg:person.0657606671.61 schema:familyName Dellamonica
178 schema:givenName P.
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657606671.61
180 rdf:type schema:Person
181 grid-institutes:grid.428999.7 schema:alternateName Pasteur Institute, Hospital and Mycology Unit, 25 rue du Dr. Roux, F 75015, Paris, France
182 schema:name Pasteur Institute, Hospital and Mycology Unit, 25 rue du Dr. Roux, F 75015, Paris, France
183 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...